OMVOH

Registered
Stylized Mark

Key Information

Serial Number

Registration Number

Status

Registered

Ownership

EL

Owner Name

Type: Organization / Corporation

Address

Lilly Corporate Center
Indianapolis, IN 46285

Critical Dates

First Use Date

Nov 13, 2023

Filing Date

Sep 23, 2021

Registration Date

Oct 29, 2024

Mark Descriptions

Goods

Class 5
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of inflammatory bowel disease and autoimmune diseases and disorders

Services

Class 44
Medical information services in the field of inflammatory bowel disease and autoimmune diseases and disorders

Mark Elements

Text Mark
OMVOH
Category
Trademark
Standard Characters
No
Color Claim
Yes
Drawing/Image Description

The mark consists of stylized literal element "omvoh". The "o", "m", "o" and "h" are blue. The "v" consists of bands of blue and green.

Color Details

The color(s) blue and green is/are claimed as a feature of the mark.

Data source: USPTO TSDR
View on USPTO website

Trademark Timeline

First Use

Nov 13, 2023

Filing Date

Sep 23, 2021

Publication Date

Jul 19, 2022

Registration Date

Oct 29, 2024

USPTO Records

Title
Date
Category
Source
Pages
Format
Actions
Notice of Registration Email
ERO(34 KB)
Oct 29, 2024
Unknown
CMS
1
XML
Registration Certificate
ORC(381 KB)
Oct 29, 2024
Outgoing
CMS
1
PDF
TRAM Snapshot of App at Pub for Oppostn (Part 1)
PST(61 KB)
Sep 23, 2024
Unknown
CMS
2
XML
TRAM Snapshot of App at Pub for Oppostn (Part 2)
PST(61 KB)
Sep 23, 2024
Unknown
CMS
2
PNG
Notice of Acceptance of SOU - E
ESO(30 KB)
Sep 23, 2024
Unknown
CMS
1
XML
AAU Processing Complete (Part 1)
APC(59 KB)
Sep 18, 2024
Unknown
CMS
2
XML
AAU Processing Complete (Part 2)
APC(59 KB)
Sep 18, 2024
Unknown
CMS
2
PNG
Statement of Use (Part 1)
SOU
Jul 17, 2024
Incoming
TICRS
5
XML
Statement of Use (Part 2)
SOU
Jul 17, 2024
Incoming
TICRS
5
JPEG
Statement of Use (Part 3)
SOU
Jul 17, 2024
Incoming
TICRS
5
JPEG
Statement of Use (Part 4)
SOU
Jul 17, 2024
Incoming
TICRS
5
JPEG
Statement of Use (Part 5)
SOU
Jul 17, 2024
Incoming
TICRS
5
TIFF
Specimen (Part 1)
SPE
Jul 17, 2024
Specimens
TICRS
3
JPEG
Specimen (Part 2)
SPE
Jul 17, 2024
Specimens
TICRS
3
JPEG
Specimen (Part 3)
SPE
Jul 17, 2024
Specimens
TICRS
3
JPEG
ITU Unit Action (Part 1)
IUA
Feb 20, 2024
TRAM Snapshot
TICRS
2
XML
ITU Unit Action (Part 2)
IUA
Feb 20, 2024
TRAM Snapshot
TICRS
2
JPEG
ITU Extension Approval
AER
Feb 20, 2024
Outgoing
TICRS
1
XML
Extension of Time to File SOU (Part 1)
ESU
Feb 19, 2024
Incoming
TICRS
2
XML
Extension of Time to File SOU (Part 2)
ESU
Feb 19, 2024
Incoming
TICRS
2
TIFF
ITU Unit Action (Part 1)
IUA
Aug 17, 2023
TRAM Snapshot
TICRS
2
XML
ITU Unit Action (Part 2)
IUA
Aug 17, 2023
TRAM Snapshot
TICRS
2
JPEG
ITU Extension Approval
AER
Aug 17, 2023
Outgoing
TICRS
1
XML
Extension of Time to File SOU
ESU
Aug 15, 2023
Incoming
TICRS
1
XML
ITU Unit Action (Part 1)
IUA
Feb 17, 2023
TRAM Snapshot
TICRS
2
XML

AI AssessmentCached Mar 12, 2026, 07:17 AM
Cached

AI-generated analysis of USPTO data for this trademark. WARNING: Content may not be accurate or up to date. Validate all responses.

Trademark Summary

The stylized mark OMVOH (in blue and green) covers pharmaceutical preparations for treating inflammatory bowel disease and autoimmune diseases in Class 005, and medical information services in the field of inflammatory bowel disease and autoimmune diseases in Class 044. It is owned by Eli Lilly and Company of Indianapolis, Indiana. The mark is registered on the Principal Register as of October 29, 2024, with no active oppositions or legal proceedings.

Recent Activity

Filed on September 23, 2021, the application was published for opposition on July 19, 2022, followed by a Notice of Allowance on September 13, 2022. After three extensions of time to file a Statement of Use, the Statement of Use was accepted on September 23, 2024, leading to registration on October 29, 2024.
USPTO
AI Analysis
v2.8.0
Generated Mar 12, 2026, 07:17 AM

Never miss important updates for this trademark

Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.